Current role
Annette Matthies
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Annette Matthies
Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Annette Matthies was appointed Chief Business Officer, effective June 1, 2023.
“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Elicio Therapeutics, Inc. (ELTX)
SEC 8-K
Current2023-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Itzhak D. Goldberg Chairman
- Julian Adams Chairman, Board Member
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.